EZCOL B V has a total of 15 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Netherlands. Its main competitors in its focus markets pharmaceuticals and foods and drinks are MicroBiome Therapeutics LLC, NATURAL ALTERNATIVES INTERNATIONAL INC and THYLABISCO AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Netherlands | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Suters Robertus Christiaan Josephus | 11 |
#2 | Mastroleo Felice | 10 |
#3 | Wattiez Ruddy | 10 |
#4 | Ronald Peter Mensink | 2 |
#5 | Emeis Josephus Jan | 2 |
#6 | Robertus Christiaan Josephus Suters | 2 |
#7 | Jogchum Plat | 2 |
#8 | Mensink Ronald Peter | 1 |
#9 | Plat Jogchum | 1 |
#10 | Lasseur Christophe | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020263078A1 | Rhodospirillum rubrum cells that lower plasma cholesterol while leaving other serum protein levels unaffected | |
WO2020130813A1 | Composition for use in a method for lowering of ldl-cholesterol in plasma | |
NL2024271B1 | Rhodospirillum rubrum cells that lower plasma cholesterol while leaving other serum protein levels unaffected | |
CN110799202A | Cellular extracts and food supplements for lowering LDL-cholesterol |